Targeting the CB2 receptor for immune modulation.
Early work on the biology of the components of Cannabis sativa showed evidence for a potential influence on immune regulation. With the discovery of a peripheral cannabinoid receptor associated with immune cells, many laboratories have sought to link the immunoregulatory activities of cannabinoid compounds with this receptor, hoping that such compounds would lack the psychoactive effects of marijuana and other nonspecific cannabinoid agonists. In this report, the authors investigate the role of the cannabinoid CB2 receptor in immune regulation, with particular emphasis on compounds shown to regulate immune cell recruitment. The authors conclude by using the immune cell recruitment model to rationalise cannabinoid CB2 receptor-specific effects in modulating immune disease, particularly the increasing evidence for its role in experimental autoimmune encephalomyelitis and in influencing bone density.
Lunn
Charles A
CA
Schering-Plough Research Institute, Department of New Lead Discovery, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA. charles.lunn@spcorp.com
Reich
Eva-Pia
EP
Bober
Loretta
L
D000818:Animals; D002186:Cannabinoids / Q000008:administration & dosage* / Q000737:chemistry; D002188:Cannabis / Q000502:physiology; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy / Q000276:immunology; D043885:Receptor, Cannabinoid, CB2 / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism*
D002186:Cannabinoids; D043885:Receptor, Cannabinoid, CB2